← Back to Methodology
RQS Scoring Log

5-Amino-1MQ

Peptide-Adjacent· Animal / In Vitro· Scored May 2026· View compound profile →
28 /100
Weak Evidence
7 dimensions · 100 points total · Methodology by PeptideClear
Dimension Breakdown
DimensionScoring NotesScore
Study Design
Mouse obesity and adipogenesis studies. In vitro NNMT inhibition assays. No human trials published. Animal/in vitro.
 5 / 25
Sample Size
No human participants.
 0 / 20
Replication
Primarily single research group (Miguelina Bhargava / Pharmacological Sciences, various). Limited independent replication.
 5 / 20
Journal Impact Factor
Published in lower-tier pharmacology and metabolism journals. No high-impact journal primary data.
 8 / 15
Funding Independence
Academic funded. No significant commercial interests in original research.
 7 / 10
Population Diversity
Animal/in vitro. Not applicable.
 0 / 5
Researcher h-Index
Researchers have moderate academic profiles; primary investigators have h-Indexes in 10-20 range. Capped at 5.
 3 / 5
Animal Only Note
This score reflects evidence in humans. Animal and in vitro evidence may be substantially stronger than the score suggests — this compound has not yet been studied in human trials.
Scored by the PeptideClear editorial team using publicly available literature. Sources: PubMed (study design, sample size, replication) · ScimagoJR (journal impact factor) · Google Scholar (researcher h-Index) · Primary papers (funding disclosure). Scores are reviewed as new research is published.